In our study, suppression of STAT3 activation by TSG-6 resulted in reduced hepatic steatosis and hepatic TG level, which was at odds with our assumption that STAT3 activation was localized within hepatocytes. The gene discussed is TNFAIP6; the disease is fatty liver disease.